Company intelligence / Profile preview

Silfradent

Santa Sofia, Emilia-Romagna, Italysilfradent.com ↗

Ownership: Private
Development stage: Other

Overview

Silfradent’s CGF platform and related medical devices are commercially available and used globally in dental surgery, implantology, bone-tissue regeneration procedures, and anti-aging therapies. The company collaborates with international research groups to develop protocols for growth factor activation and piezoelectric microsurgery. No clinical trial data typical of drug development companies; products are CE certified medical devices.

Therapeutic areas: RheumatologyOther
Modalities: DeviceAutologous blood component processing system
Industry: Surgical Medical Devices

Partnerships

Collaborations with European universities on periodontal researchInternational Research Excellence Group of doctors across specialties

Beyond the preview

Go deeper on Silfradent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silfradent.

Explore the full profile